Immortal Time and Selection Biases in Study of Direct-Acting Antiviral Treatment and Hepatitis C Outcomes

被引：1
|
作者：
Lam, Laurent [1 ,2 ]
Carrat, Fabrice [1 ]
机构：
[1] Sorbonne Univ, Inst Natl St & Rech medicale, Inst Pierre Louis Epidemiol & St Publ, Paris, France
[2] Inst Pierre Louis Epidemiologieet Sante Publ, 27 rue Chaligny, F-75571 Paris 12, France
来源：
JAMA INTERNAL MEDICINE | 2023年 / 183卷 / 06期
关键词：
D O I：
10.1001/jamainternmed.2023.0554
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：624 / 624
页数：1
相关论文
共 50 条
  • [1] Immortal Time and Selection Biases in Study of Direct-Acting Antiviral Treatment and Hepatitis C Outcomes-Reply
    Ogawa, Eiichi
    Yeo, Yee Hui
    Nguyen, Mindie H.
    JAMA INTERNAL MEDICINE, 2023, 183 (06) : 626 - 626
  • [2] Direct-acting antiviral treatment for hepatitis C
    Holmes, Jacinta A.
    Rutledge, Stephanie M.
    Chung, Raymond T.
    LANCET, 2019, 393 (10179): : 1392 - 1394
  • [3] Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
    Stelliana Goutzamanis
    Danielle Horyniak
    Joseph S. Doyle
    Margaret Hellard
    Peter Higgs
    Harm Reduction Journal, 18
  • [4] Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
    Goutzamanis, Stelliana
    Horyniak, Danielle
    Doyle, Joseph S.
    Hellard, Margaret
    Higgs, Peter
    HARM REDUCTION JOURNAL, 2021, 18 (01)
  • [5] Post-crisis imaginaries in the time of direct-acting antiviral hepatitis C treatment
    Fomiatti, Renae
    Farrugia, Adrian
    Fraser, Suzanne
    Moore, David
    Edwards, Michael
    Treloar, Carla
    TIME & SOCIETY, 2023, 32 (01) : 50 - 74
  • [6] Outcomes of Direct-Acting Antiviral Treatment of Psychiatric Patients with Comorbid Hepatitis C Virus Infection
    Gayam, Vijay
    Jegede, Oluwole
    Tiongson, Benjamin
    Mandal, Amrendra Kumar
    Sidhu, Jasdeep
    Garlapati, Pavani
    DIGESTIVE DISEASES, 2020, 38 (03) : 232 - 239
  • [7] Barriers to Treatment of Hepatitis C Virus in the Direct-Acting Antiviral Era
    Ramers, Christian B.
    Liu, Jie
    Frenette, Catherine
    CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES, 2019, 11 (02) : 92 - 102
  • [8] Review of direct-acting antiviral agents for the treatment of chronic hepatitis C
    Shah, Nihar
    Pierce, Tracey
    Kowdley, Kris V.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (09) : 1107 - 1121
  • [9] Direct-acting antiviral treatment of acute hepatitis C virus infections
    Misra, Suresh
    Dieterich, Douglas T.
    Saberi, Behnam
    Kushner, Tatyana
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (08) : 599 - 610
  • [10] Barriers to Treatment of Hepatitis C Virus in the Direct-Acting Antiviral Era
    Christian B. Ramers
    Jie Liu
    Catherine Frenette
    Current Treatment Options in Infectious Diseases, 2019, 11 : 92 - 102
12345